SGP
The Stockland quarterly update was fairly bullish, I thought, for housing and housing development in general.
They mention defaults are up, which is always a worry, but generally speaking inquiries and sales holding up is very positive.
At the end of the day I just can’t get behind the story, that the repricing of mortgage rates won’t weigh more heavily on this kind of data.
We have DXS and LLC in the direct equity sleeve (two of the poorer performing, deeper value names) to give us REIT exposure, although the office sectoral exposure (overhang!) affects those two more than the diversifieds like SGP.
RWC and JHX are far more concentrated into the home/resi section, and are industrials/building materials companies not REITs, but the same thematic/central-question is clearly at play; where do housing volumes wind up in response to the cycle.
RWC posted good quarterly sales, yesterday, however we note that volumes ex acquisitions are effectively zero, and possibly worse in Asia Pac; the good sales outcome was purely a) acquisitions and b) pricing power ex acquisitions.
Still, pricing power is a good thing, and the data suggest that being blanket negative on these types of companies might be the wrong idea.
Circling back to our original point, it is hard to go and buy names that run squarely counter to your macro view.
So, we won’t, without compelling reason (usually value, or a balance sheet that gives rise to quality-value type considerations).
Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Please note that past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.